European regulators have recommended Roche's RoActemra be approved to treat moderate to severe rheumatoid arthritis. The novel drug, known as …
New data shows Roche's Actemra (tocilizumab) increases the disease remission rate in rheumatoid arthritis (RA) sufferers. The company says the …
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership

